← All Guides / Asthma & COPD
GCC Nursing Guide — Asthma & COPD
Respiratory GCC Context GINA / GOLD / BTS Guidelines Updated Apr 2026
🌬️

Asthma — Pathophysiology

Asthma is a chronic inflammatory airway disease characterised by reversible airway obstruction, bronchial hyperresponsiveness, and airway inflammation. Unlike COPD, obstruction is largely reversible with bronchodilators.

Inflammatory Phenotypes

Eosinophilic

Most common. Th2-driven. Responds well to ICS, anti-IL5 biologics. Associated with atopy, allergic rhinitis.

Neutrophilic

Driven by infections, pollution, obesity, smoking. Less steroid-responsive. Linked to severe/refractory asthma.

📊

GINA Classification

IntermittentSymptoms ≤2/wk, no nocturnal, normal PEFR
Mild Persistent>2/wk but <daily, nocturnal >2/mo
Moderate PersistentDaily symptoms, nocturnal >1/wk, PEFR 60–80%
Severe PersistentContinuous, frequent nocturnal, PEFR <60%

GINA 2024 now prefers track-1 (ICS-containing reliever) approach. Step-up/step-down based on control, not initial severity alone.

🌍

Asthma in the GCC Region

Prevalence

Asthma prevalence in Gulf states is among the highest globally — up to 20–25% in some paediatric populations. Saudi Arabia, UAE, Kuwait all show above-world-average rates.

Environmental Triggers
Sandstorms (Haboob) Dust mites (indoor AC) Camel dander Shisha smoke Extreme heat Air pollution
Cultural Considerations

Shisha smoking is normalised across GCC, significantly worsening asthma control. Many patients underreport shisha use. Sandstorm events (haboob) cause predictable acute exacerbation surges in emergency departments.

💨

COPD — Pathophysiology

COPD is a progressive, largely irreversible airflow limitation caused by abnormal inflammatory response to noxious particles/gases. Includes emphysema (alveolar destruction) and chronic bronchitis (mucus hypersecretion, cough ≥3 months ×2 consecutive years).

Mechanism: neutrophil/macrophage inflammation → proteases destroy alveolar walls → loss of elastic recoil → air trapping → hyperinflation → impaired gas exchange.

⚠️

Type 2 Respiratory Failure risk: Chronic CO₂ retention shifts ventilatory drive to hypoxic stimulus — avoid high-flow O₂ (target SpO₂ 88–92%).

📈

GOLD Staging

By FEV₁% (post-bronchodilator, FEV₁/FVC <0.7)
GOLD 1FEV₁ ≥80%Mild
GOLD 2FEV₁ 50–79%Moderate
GOLD 3FEV₁ 30–49%Severe
GOLD 4FEV₁ <30%Very Severe
GOLD Groups (symptom + exacerbation history)
Group A

Low symptoms (mMRC 0–1 / CAT <10), 0–1 exacerbation (no hospitalisation)

Group B

High symptoms (mMRC ≥2 / CAT ≥10), 0–1 exacerbation (no hospitalisation)

Group E

≥2 exacerbations or ≥1 hospitalisation — regardless of symptoms (GOLD 2023 merged C+D)

🔬

Spirometry & Reversibility

Obstruction Criterion

FEV₁/FVC < 0.7 post-bronchodilator confirms persistent airflow limitation. Use lower limit of normal (LLN) in elderly to avoid over-diagnosis.

Reversibility Testing

Give salbutamol 400mcg (4 × 100mcg puffs) via spacer. Repeat spirometry after 15 minutes. Positive reversibility = FEV₁ increase ≥12% AND ≥200mL — suggests asthma component.

Asthma vs COPD

Asthma: fully reversible, onset earlier, atopic history, eosinophilia, variable symptoms. COPD: incomplete reversibility, smoking/exposure history, progressive, age >40. ACO (Asthma-COPD Overlap) — features of both.

🏥

COPD in the GCC

Shisha as Primary Driver

Shisha (water pipe/hookah) smoking is a major but under-recognised cause of COPD in GCC. Patients often do not consider themselves "smokers." Shisha is smoked for longer sessions, producing greater toxic gas volumes per session than cigarettes.

Occupational Exposure

Construction workers (cement/silica dust), oil and gas workers, agricultural workers in rural areas — all carry significant COPD risk. Occupational history is essential in GCC COPD assessment.

Underdiagnosis — Especially in Women

COPD is significantly underdiagnosed in GCC women. Biomass fuel exposure (cooking), indoor pollution, passive shisha smoke, and cultural reluctance to present to services all contribute. Spirometry access remains limited in primary care across the region.

Clinical Approach

Always ask about shisha history specifically. Use Arabic-language validated questionnaires (mMRC dyspnoea scale, CAT) where possible. Ensure spirometry interpretation accounts for reference ranges appropriate to Middle Eastern populations.

🚨

Acute Asthma — Severity Assessment (BTS)

Parameter Moderate Severe Life-Threatening
PEFR50–75% best/predicted33–50% best/predicted<33% best/predicted
SpO₂>94%May be reduced<92%
Resp RateIncreased>25 breaths/minMay be bradypnoeic (fatigue)
Heart RateIncreased>110 bpmBradycardia / dysrhythmia
SpeechFull sentencesCannot complete sentencesCannot speak
FeaturesSilent chest, cyanosis, exhaustion, confusion, coma
ABG / PaCO₂NormalNormal (hyperventilating)Normal/raised PaCO₂ = DANGER SIGN (tiring)
🔴

Near-fatal asthma indicators: Previous ITU admission, previous intubation/ventilation, recent rapid onset attack, brittle asthma. These patients need immediate senior review.

🧮

Interactive Asthma Severity Classifier

Enter Patient Parameters

💊

Treatment Protocol

  1. Oxygen: Titrate to SpO₂ 94–98%. Avoid hypoxia; use face mask or nasal cannulae. High-flow if SpO₂ low and no CO₂ retention history.
  2. Salbutamol 5mg nebulised back-to-back every 20 minutes for the first hour (continuous nebulisation if necessary). Driven by O₂ (6–8 L/min).
  3. Ipratropium 0.5mg nebulised — add in severe and life-threatening asthma, every 4–6 hours.
  4. Systemic steroids: IV hydrocortisone 200mg STAT (or oral prednisolone 40–50mg). Continue for 5 days minimum.
  5. IV Magnesium sulphate 2g over 20 min — in life-threatening asthma or those not responding to initial treatment. Single dose.
  6. Heliox / CPAP / NIV — consider in ICU setting. Intubation is last resort — high risk in acute asthma due to dynamic hyperinflation and breath stacking.

Discharge Criteria & Step-Up

Safe Discharge Criteria
  • PEFR >75% best/predicted (sustained for 1 hour)
  • SpO₂ >94% on room air
  • Clinically improved — no wheeze, normal speaking
  • Able to use inhaler correctly
  • Understands follow-up plan
  • Has written asthma action plan
Step-Up Medication on Discharge

Ensure ICS/LABA continued or initiated. Prescribe prednisolone course. SABA reliever reviewed. Trigger identification documented. Follow-up with GP or respiratory clinic within 2 weeks.

⚠️

Never discharge without demonstrating correct inhaler technique and providing a written action plan.

📋

AECOPD Definition & Severity

ℹ️

AECOPD Definition: An acute event characterised by a sustained worsening of the patient's respiratory symptoms that is beyond normal day-to-day variations and leads to a change in medication.

Mild
Managed at home
  • Increased breathlessness
  • Increased sputum volume
  • Change in sputum colour
  • SABA alone sufficient
  • Self-management plan activated
Moderate
Hospital admission required
  • Requires hospitalisation
  • Systemic corticosteroids needed
  • Antibiotics if indicated
  • Increased bronchodilators
  • Monitoring & reassessment
Severe
ICU / HDU level care
  • Respiratory failure (Type 1 or 2)
  • Altered consciousness
  • Haemodynamic instability
  • NIV or intubation required
  • Senior/ITU review urgently
🎯

Controlled Oxygen Therapy — KEY PRIORITY

🔴

Target SpO₂ 88–92% in COPD patients with risk of Type 2 respiratory failure

High-flow oxygen can suppress hypoxic drive in chronic CO₂ retainers → worsening hypercapnia → respiratory acidosis → coma.

Venturi Mask (preferred in AECOPD)
  • 24% (blue) = ~4 L/min — start here if SpO₂ at/above target
  • 28% (white) = ~4 L/min — if SpO₂ 85–88%
  • 35% (yellow) / 40% (red) — only with close ABG monitoring
  • Accurate FiO₂ delivery regardless of flow rate changes
Assessment & ABG Monitoring
  • Baseline ABG on air (or 28% if distressed) on admission
  • Repeat ABG at 30–60 min after starting O₂
  • Watch: rising PaCO₂, falling pH (respiratory acidosis)
  • pH <7.35 with raised PaCO₂ = consider NIV urgently
  • Document O₂ prescription with target SpO₂ range
💊

AECOPD Treatment Protocol

Bronchodilators

Salbutamol 2.5–5mg + ipratropium 0.5mg nebulised every 4–6 hours. Increase frequency based on response. Transition to inhaler as patient improves.

Systemic Corticosteroids

Prednisolone 30–40mg oral daily × 5 days. No benefit from longer courses — GOLD evidence. IV hydrocortisone if oral route not possible.

Antibiotics

Indicated if: purulent sputum (green/yellow) AND increased dyspnoea or increased volume. First line: amoxicillin 500mg TDS or doxycycline 200mg loading then 100mg OD or clarithromycin 500mg BD × 5 days.

⚠️

GCC: consider local antibiotic resistance patterns — co-amoxiclav or respiratory fluoroquinolone (levofloxacin) may be preferred in severe cases or recent antibiotic use.

🫁

NIV (BiPAP) in AECOPD

Indications for NIV
  • pH <7.35 with PaCO₂ >6kPa (hypercapnic respiratory failure)
  • Persistent hypoxia despite controlled O₂
  • Respiratory rate >25 and distress despite bronchodilators
  • Failure to improve with maximum medical therapy
NIV Settings (typical start)
  • IPAP: 10–15 cmH₂O (titrate up to 20–25)
  • EPAP: 4–5 cmH₂O
  • FiO₂: titrate to SpO₂ 88–92%
  • Reassess ABG after 1 hour
Contraindications

Impaired consciousness/airway protection, facial trauma, vomiting, haemodynamic instability. → These require intubation consideration.

🏥

Physiotherapy in AECOPD

Active Cycle of Breathing Techniques (ACBT)
  1. Breathing control — relaxed tidal breathing, diaphragmatic focus
  2. Thoracic expansion exercises — 3–4 deep inspirations ± breath hold
  3. Forced expiration technique (FET/Huffing) — mid-high lung volume huff
  4. Repeat cycle — assess sputum clearance
Positioning

High sitting (45–90°) optimises diaphragmatic excursion. Pursed lip breathing reduces dynamic airway collapse and air trapping. Forward lean with hands on knees — accessory muscle use.

Discharge & COPD Action Plan

Discharge Criteria
  • SpO₂ stable on usual home O₂ or air
  • Back on pre-admission inhaler regimen
  • Clinically stable >12 hours
  • No IV treatment needed
  • Can mobilise adequately, eat/drink
  • COPD action plan provided/reinforced
COPD Action Plan Includes

When to increase SABA frequency. When to start rescue prednisolone (green/amber/red zones). When to start rescue antibiotics (if purulent sputum). When to go to emergency department immediately. GP/clinic follow-up within 2 weeks of discharge.

📢

Up to 90% of patients use inhalers incorrectly. Poor technique is one of the most significant and modifiable causes of poor asthma/COPD control. Nursing inhaler education is a high-impact intervention.

💨

pMDI — Pressurised Metered Dose Inhaler

Examples: Ventolin (salbutamol), Clenil (beclometasone), Seretide (salmeterol/fluticasone), Fostair

1
Shake the inhaler vigorously 5 times
2
Remove cap and inspect mouthpiece for debris
3
Breathe out gently and completely (not into inhaler)
4
Actuate at start of a slow, deep breath — coordinate inhaler press with inhalation
5
Breathe in slowly over 4–5 seconds — avoid fast turbulent flow
6
Hold breath 10 seconds (or as long as comfortable) to allow deposition
7
Wait 30–60 seconds before second dose. Shake again before second actuation
⚠️

Common error: actuating before inhaling, or inhaling too fast. Cold freon effect may stop inhalation prematurely — not drug delivery failure.

🔵

Spacer Device

Spacers are essential adjuncts — recommended for all ICS pMDIs and for SABA in acute attacks.

Why Spacers Matter
  • Eliminates need to coordinate actuation with inhalation
  • Reduces oropharyngeal deposition of ICS (less thrush/dysphonia)
  • Increases lung deposition by ~20–30%
  • Essential for elderly, children, hand-strength limited patients
  • Equivalent to nebuliser for mild-moderate acute asthma
Spacer Technique
1
Shake inhaler, attach to spacer
2
Place mouthpiece between lips (or use mask)
3
Fire ONE puff into spacer
4
Breathe in and out slowly 4–5 times (tidal breathing) — OR one slow deep breath
5
Wait 30 seconds before next puff — do NOT multi-dose into spacer
🌀

DPI — Dry Powder Inhalers

Examples: Turbuhaler (Symbicort, Bricanyl), Accuhaler (Seretide), Ellipta (Relvar, Incruse, Anoro)

ℹ️

DPIs require a rapid, forceful inhalation — opposite to pMDI. Breath-actuated: no coordination needed but inspiratory effort essential. NOT suitable for severe acute attacks.

1
Load the device (Turbuhaler: twist and click; Accuhaler: slide lever; Ellipta: open cover)
2
Hold upright — especially Turbuhaler (tilting reduces dose)
3
Breathe out completely (not into device)
4
Rapid, deep breath — fast forceful inhalation creates turbulence to deaggregate powder
5
Hold 10 seconds, then breathe normally

Note: DPIs are recommended during Ramadan fasting (minimal systemic absorption, acceptable per majority of Islamic scholarship).

💧

SMI — Soft Mist Inhaler (Respimat)

Examples: Spiriva Respimat (tiotropium), Stiolto, Spiolto

  • Produces a slow, sustained soft mist — better lung deposition than pMDI
  • No propellant, no powder — useful for patients unable to use pMDI or DPI
  • Requires slow inhalation (like pMDI) but easier coordination than pMDI
  • Rotate base to load, open cap, breathe out, inhale slowly over 3–4 seconds
Nebuliser — When to Use
  • Acute severe or life-threatening asthma
  • Patients unable to use any inhaler device
  • High-dose delivery required (AECOPD hospital setting)
  • Driven by oxygen in asthma (6–8 L/min); air-driven in COPD Type 2 risk
⚠️

In COPD, nebulise with compressed air (not O₂) to avoid CO₂ retention risk. Provide supplemental O₂ via nasal cannulae simultaneously.

📝

Nursing Inhaler Technique Assessment Checklist

Use placebo/trainer inhalers to assess technique. Tick off each item. Checked items saved locally.

pMDI Checklist
DPI Checklist
🏃

Pulmonary Rehabilitation (PR)

Strongest evidence-based intervention for COPD after smoking cessation. Reduces hospitalisation, improves exercise capacity, QOL, and breathlessness.

Programme Structure
  • 6–8 week programme, 2–3 sessions per week
  • Exercise training (aerobic + resistance)
  • Education sessions (disease management, nutrition, anxiety)
  • Referral: after any hospitalisation for AECOPD (within 4 weeks)
  • MRC dyspnoea grade ≥3 or CAT ≥10
GCC Considerations

PR programmes are expanding across GCC. Summer heat limits outdoor exercise — indoor air-conditioned facilities important. Gender-separated classes may be preferred. Ramadan scheduling adjustments may be needed.

🌬️

Long-Term Oxygen Therapy (LTOT)

Indications (NICE/BTS)
  • PaO₂ ≤7.3 kPa on two assessments ≥3 weeks apart when stable
  • PaO₂ 7.3–8 kPa if secondary polycythaemia, pulmonary hypertension, peripheral oedema, or nocturnal hypoxaemia
  • Assessed when patient clinically stable (4–8 weeks post-exacerbation)
Prescription
  • Minimum 15 hours/day — including during sleep
  • Target SpO₂ 88–92% (COPD) or 94–98% (non-hypercapnic)
  • Home oxygen concentrator — standard in GCC homes
  • Portable cylinder for mobility
🔥

Fire Safety: No smoking near oxygen equipment. Keep 2m from flames. Patient/family education essential. O₂ enriches fire dramatically.

😴

Home NIV & OHS

Indications for Home BiPAP
  • COPD with chronic hypercapnia (PaCO₂ >6kPa when stable)
  • Obesity Hypoventilation Syndrome (OHS) — common in GCC given high obesity rates
  • Recurrent AECOPD requiring NIV
  • Combination with LTOT in selected patients
Nursing Role in Home NIV

Mask fitting and interface selection. Leak management. Humidifier use in arid GCC climate. Adherence monitoring. Troubleshooting pressure-related issues. Annual reassessment with ABG.

💉

Vaccinations

Recommended for All Asthma/COPD Patients
InfluenzaAnnual — reduces exacerbations 50%
Pneumococcal (PCV13)Once (+ booster per local guidance)
Pneumococcal (PPSV23)Once, repeat at 5 years if high risk
COVID-19Per national GCC schedule
Pertussis (Tdap)If not recently vaccinated

Hajj/Umrah pilgrims: additional meningococcal and additional influenza recommendations per Saudi MOH.

🚭

Smoking Cessation

Smoking cessation is the single most effective intervention for slowing COPD progression and reducing exacerbation frequency. Every clinical contact is an opportunity.

Pharmacotherapy
  • Varenicline (Champix) — most effective, reduces cravings + withdrawal. 12-week course.
  • NRT — patch, gum, lozenge, spray. Combination NRT most effective.
  • Bupropion — antidepressant with cessation evidence. Second-line.
Brief Motivational Counselling

5 A's model: Ask (tobacco status), Advise (clear message), Assess (readiness), Assist (cessation plan), Arrange (follow-up). Even brief advice (3 minutes) increases quit rates by 50–70% over no advice.

GCC-Specific: Shisha Cessation

Patients do not identify as smokers. Motivational interview technique — explore perceived benefits of shisha (social, relaxation). Emphasise 1 hour shisha = 100–200 cigarettes. NRT evidence applies. Family/social norm challenge key.

📋

COPD Self-Management Plan

GREEN Zone — Stable
  • Continue regular inhalers as prescribed
  • Exercise as able
  • Take medications as scheduled
  • Monitor symptoms daily
AMBER Zone — Worsening
  • Increase SABA frequency to 4-hourly
  • Start rescue prednisolone 30–40mg if breathlessness worsening
  • Start antibiotics if sputum purulent/increased
  • Contact GP/clinic if no improvement in 48h
RED Zone — Emergency
  • CALL EMERGENCY (911 / 999 / 112)
  • Not responding to increased bronchodilators
  • SpO₂ dropping below 85% on home monitor
  • Confusion, drowsiness, unable to speak
  • Cyanosis (blue lips/fingertips)
🪔

Shisha/Hookah Smoking in the GCC

Epidemiology & Risk
  • Shisha (water pipe/nargileh/hookah) is deeply embedded in GCC social culture
  • 1 hour shisha session ≈ 100–200 cigarettes in terms of smoke volume
  • High concentrations of CO, tar, heavy metals, nicotine delivered
  • Misconception: water "filters" the smoke — it does NOT remove toxins significantly
  • Shared mouthpieces: infectious disease transmission risk (TB, COVID, herpes)
  • Major driver of COPD in younger GCC adults, including women
Impact on Asthma

Significant worsening of asthma control. Increases airway inflammation, reduces SABA effectiveness, accelerates remodelling. Many patients do not realise shisha worsens asthma.

Nursing Approach
  • Ask specifically: "Do you smoke shisha / water pipe?" — separately from cigarette question
  • Non-judgmental approach — acknowledge social significance
  • Use motivational interviewing — explore ambivalence
  • Quantify: "How many sessions per week? How long is each session?"
  • Provide factual information on toxicity
  • Offer NRT support — nicotine dependence is real with shisha
⚠️

Document shisha smoking status in clinical records as formally as cigarette smoking. It is a major risk factor that is frequently omitted.

🌪️

Sandstorms (Haboob) — Asthma Management

Haboob events are large, fast-moving dust storms common in Saudi Arabia, UAE, Kuwait, Qatar, and Oman — particularly during spring transition months. PM10 and PM2.5 levels spike dramatically, triggering asthma exacerbations en masse.

Storm Preparedness — Patient Education
  • Monitor AQI apps daily (Hawa'a, Air Quality Index UAE, Saudi EPA)
  • Stay indoors during storm events — close windows and doors
  • Use air conditioning with recirculation mode (not fresh air intake)
  • Double reliever inhaler frequency on storm days (if PEFR allows)
  • Ensure rescue inhaler is always accessible and charged
  • Wear N95 mask if outdoor exposure unavoidable
ED Surge Preparedness

Hospitals in GCC should anticipate increased acute asthma presentations 12–48 hours after major haboob events. Stock nebuliser solutions, ensure IV magnesium availability.

🐪

Camel Dander — Occupational Asthma

Camel racing is a major sport in UAE, Qatar, Oman, and Saudi Arabia. Camel breeding and herding is practiced widely across the region.

Clinical Features
  • Occupational asthma presenting in camel handlers, jockeys, groomers, veterinarians
  • Symptoms improve on rest days or holidays (classic occupational pattern)
  • Camel urinary proteins and dander are potent allergens — IgE-mediated sensitisation
  • Al Ain (UAE), Doha (Qatar), and rural Oman have highest risk populations
Nursing Assessment

Always ask about animal exposure in occupational history. Serial PEFR monitoring at work vs. away. Refer to occupational physician/allergist for specific IgE testing. Workplace risk assessment required — PPE (N95/P100 mask), reducing exposure time.

🌙

Ramadan Asthma & COPD Management

Inhaler Use During Fasting

This is a common patient concern. The majority of Islamic scholars (including Saudi and Egyptian fatwa councils) consider inhaler use permissible during Ramadan fasting as they are not nutritional and not swallowed.

  • DPIs: minimal systemic absorption — most widely accepted
  • pMDIs: generally accepted — propellant/drug doses very small
  • Nebulisers: more debate due to steam inhalation; many scholars permit for medical necessity
  • Oral prednisolone: breaks the fast — schedule use in non-fasting hours if possible
Practical Guidance
  • Reassure patients clearly: skipping inhalers during Ramadan to "fast correctly" is dangerous and unnecessary
  • Adjust twice-daily inhalers to once at Suhoor (pre-dawn) and once at Iftar (sunset)
  • Once-daily inhalers (Ellipta, Spiriva) are particularly convenient during Ramadan
  • Monitor symptoms more closely — night waking may increase
  • Dehydration during hot Ramadan months → thicker secretions → COPD exacerbation risk
  • Encourage adequate hydration at Suhoor and after Iftar
📱

Air Quality Monitoring in GCC

Recommended AQI Apps & Resources
  • IQAir / AirVisual — real-time AQI globally including all GCC cities
  • Saudi EPA (Hareer) — official Saudi air quality monitoring
  • UAE Ministry of Climate Change — AQI monitoring UAE
  • Qatar Meteorology Dept app — dust storm alerts
  • Patients should check AQI daily — high risk days >150 AQI (Unhealthy)
Patient Action by AQI
0–50 (Good)Normal activities
51–100 (Moderate)Reduce prolonged outdoor exertion
101–150 (Unhealthy sensitives)Limit outdoor activity, carry reliever
151+ (Unhealthy–Hazardous)Stay indoors, double reliever frequency, call if worsening
👩‍⚕️

COPD Specialist Nurse Pathway in GCC

Emerging Role

Specialist respiratory/COPD nurses are increasingly recognised in GCC healthcare systems, particularly in Saudi Arabia (MOH hospital networks), UAE (SEHA, Cleveland Clinic Abu Dhabi), Qatar (HMC), and Kuwait (MOH hospitals).

Key Nurse Competencies
  • Spirometry performance and interpretation
  • Inhaler technique education and assessment
  • COPD self-management plan development
  • Pulmonary rehabilitation prescription and monitoring
  • Smoking cessation brief intervention delivery
  • LTOT and home NIV patient education
  • Advance care planning conversations
Training

ARTP (Association for Respiratory Technology and Physiology) spirometry certification recognised across GCC. British Thoracic Society nursing guidelines applicable. Local MOH and JCI accreditation requirements vary by country.